Cargando…

Ultra‐Fast Insulin–Pramlintide Co‐Formulation for Improved Glucose Management in Diabetic Rats

Dual‐hormone replacement therapy with insulin and amylin in patients with type 1 diabetes has the potential to improve glucose management. Unfortunately, currently available formulations require burdensome separate injections at mealtimes and have disparate pharmacokinetics that do not mimic endogen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maikawa, Caitlin L., Chen, Peyton C., Vuong, Eric T., Nguyen, Leslee T., Mann, Joseph L., d'Aquino, Andrea I., Lal, Rayhan A., Maahs, David M., Buckingham, Bruce A., Appel, Eric A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564421/ https://www.ncbi.nlm.nih.gov/pubmed/34499434 http://dx.doi.org/10.1002/advs.202101575

Ejemplares similares

A co-formulation of supramolecularly stabilized insulin and pramlintide enhances meal-time glucagon suppression in diabetic pigs
por: Maikawa, Caitlin L., et al.
Publicado: (2020)

Full closed loop open‐source algorithm performance comparison in pigs with diabetes
por: Lal, Rayhan A., et al.
Publicado: (2021)

Use of a biomimetic hydrogel depot technology for sustained delivery of GLP-1 receptor agonists reduces burden of diabetes management
por: d’Aquino, Andrea I., et al.
Publicado: (2023)

Self-Assembled, Dilution-Responsive Hydrogels for Enhanced Thermal Stability of Insulin Biopharmaceuticals
por: Meis, Catherine M., et al.
Publicado: (2020)

Pramlintide in the Management of Insulin-Using Patients with Type 2 and Type 1 Diabetes
por: Pullman, John, et al.
Publicado: (2006)

Pramlintide, an antidiabetic, is antineoplastic in colorectal cancer and synergizes with conventional chemotherapy
por: Al-Keilani, Maha S, et al.
Publicado: (2018)

Review of pramlintide as adjunctive therapy in treatment of type 1 and type 2 diabetes
por: Ryan, Gina, et al.
Publicado: (2009)

Block copolymer composition drives function of self‐assembled nanoparticles for delivery of small‐molecule cargo
por: Maikawa, Caitlin L., et al.
Publicado: (2019)

The effect of pramlintide, an antidiabetic amylin analogue, on angiogenesis-related markers in vitro
por: Safaeian, Leila, et al.
Publicado: (2020)

Pramlintide: A Novel Therapeutic Approach for Osteosarcoma through Metabolic Reprogramming
por: Yang, Yuanzheng, et al.
Publicado: (2022)

Study of forced degradation behavior of pramlintide acetate by HPLC and LC–MS
por: Yuan, Yu, et al.
Publicado: (2017)

Randomized Comparison of Pramlintide or Mealtime Insulin Added to Basal Insulin Treatment for Patients With Type 2 Diabetes
por: Riddle, Matthew, et al.
Publicado: (2009)

Amylin and pramlintide modulate γ-secretase level and APP processing in lipid rafts
por: Mousa, Youssef M., et al.
Publicado: (2020)

Consistent tumorigenesis with self-assembled hydrogels enables high-powered murine cancer studies
por: Grosskopf, Abigail K., et al.
Publicado: (2021)

A Phase 2 Evaluation of a Novel Co-Formulation of Pramlintide and Regular Insulin to Improve Postprandial Glycemic Control in Adults with Type 1 Diabetes (T1D)
por: Edelman, Steven Victor, et al.
Publicado: (2021)

Nanoparticles Presenting Potent TLR7/8 Agonists Enhance Anti-PD-L1 Immunotherapy in Cancer Treatment
por: Smith, Anton A. A., et al.
Publicado: (2020)

Contraction of human brain vascular pericytes in response to islet amyloid polypeptide is reversed by pramlintide
por: Nuñez-Diaz, Cristina, et al.
Publicado: (2023)

SAT-LB028 Efficacy and Safety of Pramlintide as an Adjunct to Insulin U500 Therapy in Veterans with Severe Insulin Resistance
por: Oprea, Mihaela, et al.
Publicado: (2019)

Fixed ratio dosing of pramlintide with regular insulin before a standard meal in patients with type 1 diabetes
por: Riddle, M. C., et al.
Publicado: (2015)

Effect of Pramlintide on Prandial Glycemic Excursions During Closed-Loop Control in Adolescents and Young Adults With Type 1 Diabetes
por: Weinzimer, Stuart A., et al.
Publicado: (2012)

Sustained Weight Loss Following 12-Month Pramlintide Treatment as an Adjunct to Lifestyle Intervention in Obesity
por: Smith, Steve R., et al.
Publicado: (2008)

Author Correction: Amylin and pramlintide modulate γ-secretase level and APP processing in lipid rafts
por: Mousa, Youssef M., et al.
Publicado: (2020)

Zn(II) binding to pramlintide results in a structural kink, fibril formation and antifungal activity
por: Dudek, Dorota, et al.
Publicado: (2022)

Delivery of CAR-T cells in a transient injectable stimulatory hydrogel niche improves treatment of solid tumors
por: Grosskopf, Abigail K., et al.
Publicado: (2022)

Swimming With the Omnipod 5 Automated Insulin Delivery System: Connectivity in the Water
por: Hughes, Michael S., et al.
Publicado: (2023)

Injectable Biodegradable Silica Depot: Two Months of Sustained Release of the Blood Glucose Lowering Peptide, Pramlintide
por: Tyagi, Puneet, et al.
Publicado: (2022)

Cardiovascular safety assessment of pramlintide in type 2 diabetes: results from a pooled analysis of five clinical trials
por: Herrmann, Kathrin, et al.
Publicado: (2016)

A fluorescence sandwich immunoassay for the real-time continuous detection of glucose and insulin in live animals
por: Poudineh, Mahla, et al.
Publicado: (2020)

Efficacy and safety of pramlintide injection adjunct to insulin therapy in patients with type 1 diabetes mellitus: a systematic review and meta-analysis
por: Qiao, Yong-Chao, et al.
Publicado: (2017)

Pramlintide regulation of extracellular matrix (ECM) and apoptosis through mitochondrial-dependent pathways in human nucleus pulposus cells
por: Wu, Xinghuo, et al.
Publicado: (2017)

Practical Aspects and Exercise Safety Benefits of Automated Insulin Delivery Systems in Type 1 Diabetes
por: Zaharieva, Dessi P., et al.
Publicado: (2023)

Development and validation of a new robust RP-HPLC method for simultaneous quantitation of insulin and pramlintide in non-invasive and smart glucose-responsive microparticles
por: Emami, Jaber, et al.
Publicado: (2022)

Pramlintide, the synthetic analogue of amylin: physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular risk
por: Hoogwerf, Byron J, et al.
Publicado: (2008)

Impact of Disease Duration on the Effects of Pramlintide in Type 1 Diabetes: A Post Hoc Analysis of Three Clinical Trials
por: Herrmann, Kathrin, et al.
Publicado: (2016)

Injectable Nanoparticle‐Based Hydrogels Enable the Safe and Effective Deployment of Immunostimulatory CD40 Agonist Antibodies
por: Correa, Santiago, et al.
Publicado: (2022)

Pramlintide: An Amylin Analogue Protects Endothelial Cells against Oxidative Stress through Regulating Oxidative Markers and NF-κb Expression
por: Safaeian, Leila, et al.
Publicado: (2022)

Piedra no piedra /
por: D'Aquino, Alfonso
Publicado: (1992)

Cambios y continuidades : una mirada a los múltiples procesos históricos contemporáneos
por: D'Aquino, Marisa
Publicado: (2000)

Psychic interaction
por: D'Aquino, F
Publicado: (1994)

Preclinical Safety and Pharmacokinetics of Heat Stable Oxytocin in Sublingual Fast-Dissolving Tablet Formulation
por: Zhu, Changcheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u57osrupopi6s6d0j074qsf1gn